March 03, 2020
Article
NeurologyLive Insights
An overview on the Peer Exchange series, "Managing OFF Episodes in Parkinson disease."
March 02, 2020
Article
Features
Addressing risk factors early on may help curb the negative effects of cerebral small vessel disease on aging and reduce risk of neurovascular events.
March 01, 2020
Article
Clinical Insights
NeurologyLive's editor in chief Stephen D. Silberstein, MD, discussed the ways to optimizing patient care.
March 01, 2020
Article
Clinical Trial Focus
Gaboxadol is the first treatment in 50 years associated with positive change in outcomes in Angelman syndrome.
February 29, 2020
Article
Features
Leaders of the CMSC Working Group on MRI protocols and clinical guidelines express the need for a unified approach to diagnosing and monitoring multiple sclerosis.
February 27, 2020
Article
NeuroPathways
Understanding the pathophysiology of myasthenia gravis is still being determined to this day, but the neonatal Fc receptor is emerging as a potential treatment.
February 27, 2020
Article
Clinical Viewpoint
Imad Najm, MD, director of the Cleveland Clinic Epilepsy Center, detailed the ongoing efforts to transform the way health care providers diagnose and treat patients with 1 ultimate goal in mind: improving access to high-quality care.
February 26, 2020
Article
Cover Story
The Healey ALS Platform Trial learns from successful cancer drug studies to identify and accelerate new treatments for the devastating disease.
February 25, 2020
Article
Features
Two new classes of medications have quickly expanded the pool of available treatment options for patients with migraine, who now have more power than ever to choose the treatment that fits them best.
Evusheld Increased Attenuated SARS-CoV-2 Antibodies From MS B-Cell Depleting Medications
NeurologyLive® Friday 5 — June 24, 2022
Exploiting Anti-CD3 Antibodies, Relevant Biomarkers in Progressive MS: Tanuja Chitnis, MD
FDA Places Clinical Hold on Duchenne Muscular Dystrophy Drug SRP-5051 Amid Safety Concerns